Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy

Autor: Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, Dan Ou, Antonin Levy, Philippe Gorphe, Ingrid Breuskin, Sarah Atallah, Alexandre Caula, Alexandre Escande, François Janot, France Nguyen, Stéphane Temam, Eric Deutsch, Yungan Tao
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Clinical and Translational Radiation Oncology, Vol 12, Iss , Pp 8-15 (2018)
Druh dokumentu: article
ISSN: 2405-6308
DOI: 10.1016/j.ctro.2018.07.002
Popis: Objective: To study the prognostic value of leukocyte increase in a retrospective cohort of locally advanced head and neck squamous cell carcinoma (HNSCC) patients receiving definitive concurrent cisplatin and radiation. Materials and methods: Clinical records of consecutive previously untreated locally advanced HNSCC patients treated in our Institution between March 2006 and October 2012 by concurrent cisplatin (100 mg/m2, every 3 weeks) and radiation (70 Gy in 7 weeks) were collected. The prognostic value of pretreatment leukocyte increase was examined, with focus on patterns of relapse and survival. Leukocytosis and neutrophilia were defined as a leukocyte count or a neutrophils count exceeding 10 and 7.5 G/L, respectively. Results: We identified 193 patients, all treated with concurrent cisplatin-based chemoradiotherapy. Respectively 24% and 20% patients displayed baseline leukocytosis or neutrophilia. Mean leukocyte count were significantly more elevated in current smokers, patients with performance status (PS) >0, T4 and less in HPV + tumor. The 5-year actuarial overall survival (OS) and progression-free survival (PFS) were 56% and 51% respectively. In univariate analysis, both leukocytosis and neutrophilia were strongly associated with worse OS and PFS (p
Databáze: Directory of Open Access Journals